Venturi Wealth Management LLC Increases Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Venturi Wealth Management LLC grew its stake in DocuSign, Inc. (NASDAQ:DOCU) by 19.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,722 shares of the company’s stock after buying an additional 1,114 shares during the period. Venturi Wealth Management LLC’s holdings in DocuSign were worth $417,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the stock. Massmutual Trust Co. FSB ADV grew its position in shares of DocuSign by 5,000.0% during the second quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $27,000 after acquiring an additional 500 shares during the last quarter. Mather Group LLC. boosted its stake in DocuSign by 4,338.5% during the 2nd quarter. Mather Group LLC. now owns 577 shares of the company’s stock worth $31,000 after purchasing an additional 564 shares during the period. Reston Wealth Management LLC purchased a new stake in DocuSign during the 3rd quarter valued at approximately $47,000. nVerses Capital LLC purchased a new position in shares of DocuSign in the 2nd quarter valued at approximately $48,000. Finally, Quarry LP acquired a new position in shares of DocuSign in the second quarter valued at approximately $53,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at DocuSign

In other DocuSign news, Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $56.56, for a total transaction of $30,203.04. Following the completion of the sale, the director now owns 7,202 shares in the company, valued at $407,345.12. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other DocuSign news, CEO Allan C. Thygesen sold 7,725 shares of DocuSign stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $59.09, for a total value of $456,470.25. Following the completion of the transaction, the chief executive officer now directly owns 102,193 shares in the company, valued at $6,038,584.37. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $56.56, for a total value of $30,203.04. Following the transaction, the director now owns 7,202 shares of the company’s stock, valued at approximately $407,345.12. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 69,558 shares of company stock valued at $4,272,768 over the last 90 days. 1.66% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Royal Bank of Canada raised their price objective on shares of DocuSign from $52.00 to $57.00 and gave the company a “sector perform” rating in a research report on Friday, September 6th. Bank of America lifted their price target on DocuSign from $60.00 to $68.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Wells Fargo & Company boosted their price objective on shares of DocuSign from $48.00 to $50.00 and gave the stock an “underweight” rating in a report on Friday, September 6th. JMP Securities reaffirmed a “market outperform” rating and set a $84.00 price target on shares of DocuSign in a research note on Thursday, September 5th. Finally, Robert W. Baird raised their target price on shares of DocuSign from $55.00 to $59.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $63.40.

DocuSign Trading Up 1.5 %

Shares of DOCU opened at $82.47 on Wednesday. DocuSign, Inc. has a twelve month low of $40.64 and a twelve month high of $82.97. The firm has a market capitalization of $16.74 billion, a P/E ratio of 17.40, a price-to-earnings-growth ratio of 8.40 and a beta of 0.90. The stock’s fifty day simple moving average is $65.20 and its 200 day simple moving average is $58.85.

DocuSign (NASDAQ:DOCU) last released its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.17. The business had revenue of $736.03 million for the quarter, compared to analyst estimates of $727.20 million. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. The company’s revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.09 EPS. Sell-side analysts predict that DocuSign, Inc. will post 1.01 earnings per share for the current year.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.